The company began trading on Nasdaq under the name Scinai Immunotherapeutics Ltd.(SCNI) on September 7, 2023, following a corporate name change. Previously, Scinai traded on Nasdaq under the name BiondVax Pharmaceuticals Ltd. and the symbol BVXV. The CUSIP of the Company’s ADSs is 09073Q204.

Previous quarterly and annual financial reports are available on the SEC website.